SEC 13F Intelligence

Enavate Sciences GP, LLC / IMNM

Enavate Sciences GP, LLC’s Immunome Inc Position

Does Enavate Sciences GP, LLC own Immunome Inc (IMNM)? Yes — 3.61M shares worth $79M (+22.48% of its 13F portfolio) as of Q1 2026, down from 4.77M shares the prior filed quarter.

Position Value
$79M
Q1 2026
Shares
3.61M
% of Portfolio
+22.48%
Quarters Held
6
currently held

Position History IMNM

Reported value by quarter
Q4 ’24: $37MQ4 ’24Q1 ’25: $32MQ1 ’25Q2 ’25: $44MQ2 ’25Q3 ’25: $56MQ3 ’25Q4 ’25: $102MQ4 ’25Q1 ’26: $79MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20263.61M$79M+22.48%
Q4 20254.77M$102M+20.21%
Q3 20254.77M$56M+17.05%
Q2 20254.77M$44M+25.12%
Q1 20254.77M$32M+24.18%
Q4 20243.48M$37M+26.53%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Enavate Sciences GP, LLC’s full portfolio or all institutional holders of IMNM.